E-GEOD-42296 - Distinct, non-overlapping gene panels of peripheral blood gene expression predict response to infliximab therapy in rheumatoid arthritis and Crohn's disease
Released on 25 June 2013, last updated on 1 July 2013
We used microarrays to identify markers predicting responder status in infliximab treatment in 19 rheumatoid arthritis and 20 Crohn's disease patients at week 0 and week 2 of treatment. Peripheral blood samples were obtained at week 0 and week 2 of inxliximab treatment and global gene expression profiling identified markers of responder status.
transcription profiling by array
Andrea Vancsa, Attila Horvath, Bertalan Mesko, Gabor Zahuczky, Janos Podani, Karoly Palatka, Laszlo Nagy, Laszlo Steiner, Szilard Poliska, Zoltan Szekanecz, Zsolt Hollo